Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal

BioPharma DivecAMPfield lands $180M to build gut disease drug

Endpoints NewsNovo Nordisk expands in China and Czech; Cellares boosts Series D by $50M

BioPharma DiveBiogen adds more immune drugs in $1B buyout of secretive startup Raythera

Promega BlogWhat Happens When You Delay an Ebola Vaccine Booster by 18 Months?

FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara

Endpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study finds

Endpoints NewsPrepping for peptides

BioPharma DivePfizer CFO to step down; Denali sells a regulatory fast-pass

Endpoints NewsPfizer CFO to depart; GSK wins approval for UTI drug

Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea

Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study

BioWorldShanghai Pharmaceuticals discovers new IL-17A inhibitors